| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/0885066605282532 Perioperative Effects and Safety of Nesiritide Following Cardiac Surgery in ChildrenHeart Care International, Santo Domingo, Dominican Republic; Sibley Heart Center Cardiology, The McGill Building, 2835 Brandywine Road, Suite 300, Atlanta, GA 30341; simsicj{at}kidsheart.com
Heart Care International, Santo Domingo, Dominican Republic; Division of Pediatric Cardiology, Medical University of South Carolina, Charleston, SC
Heart Care International, Santo Domingo, Dominican Republic; Division of Pediatric Anesthesiology/Pediatric Critical Care, University of Missouri, Columbia, MO
Heart Care International, Santo Domingo, Dominican Republic; Division of Pediatrics/Pediatric Critical Care, University of Louisville, Louisville, KY
Heart Care International, Santo Domingo, Dominican Republic; Department of Anesthesiology, Columbia University, New York, NY
Heart Care International, Santo Domingo, Dominican Republic
Heart Care International, Santo Domingo, Dominican Republic; Department of Cardiothoracic Surgery, Montefiore Medical Center, Bronx, NY Nesiritide (Natrecor, Scios Inc), human B-type natriuretic peptide, has hemodynamic effects that may be beneficial in pediatric patients after cardiac surgery. Experience with nesiritide and pediatrics is limited. The purpose of this study was to evaluate perioperative effects and safety of nesiritide in pediatric cardiothoracic surgery. Seventeen patients with congenital heart disease undergoing cardiac surgery were given a loading dose (1 µg/kg) while on cardiopulmonary bypass (constant flow) followed by continuous infusion for 24 hours (0.01 µg/kg/min x 6 hours, then 0.02 µg/kg/min x 18 hours). A 7% decrease in mean blood pressure was seen following nesiritide loading dose on cardiopulmonary bypass. No patient required intervention for hypotension while receiving nesiritide load or infusion. Nesiritide load during surgery and continuous infusion after cardiac surgery in pediatric patients resulted in no significant hemodynamic compromise.
Key Words: B-type natriuretic peptide cardiac surgery congenital heart disease pediatrics
|